Targeting mTOR with vistusertib attenuates metabolic steatohepatitis and prevents HCC development

Inflammation Research 2026

View at publisher

Authors: Nidhi Sharma, Suriya Panneerselvam, Yogesh Chandra, Sai Balaji Andugulapati

DOI: 10.1007/s00011-026-02265-y

Cited by: 1

References: 52

Fields of Study & Subjects

PI3K/AKT/mTOR signaling in cancer Liver Disease Diagnosis and Treatment Diet Metabolism and Disease

References 52